Comparison Chart Prothena Corporation plc

Stocks

PRTA

IE00B91XRN20

Biotechnology & Medical Research

Market Closed - Nasdaq 23:00:00 29/10/2026 +03			5-day change	1st Jan Change
8.880 ^USD	-2.42%		+7.64%	-7.02%

10-15	Prothena Corp Public Ltd Insider Bought Shares Worth $920,049, According to a Recent SEC Filing	MT
10-09	Prothena Corp Public Ltd Insider Bought Shares Worth $1,821,054, According to a Recent SEC Filing	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	PROTHENA CORPORATION PLC	Bio Therapeutic Drugs	-2.42%	+7.64%	-7.02%	-16.62%	-83.96%	467M